Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 47

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

273

HTML

2273

Figures (1-9)

266

Tables (1-1)

218

Sum=3030

Dec 21, 2008 (publication date) through Nov 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Dec 21, 2008; 14(47): 7183-7191
Published online Dec 21, 2008. doi: 10.3748/wjg.14.7183

Table 1 Results of hemodynamic change in CE-US, response, and outcome after chemotherapy

	Hemodynamic change in CE-US	No. of cases (n = 34)	CEM (n = 18)	CEM + CDDP (n = 13)	Chemo + radiation (n = 3)	Response				CA19-9 reduction of less than half (n = 31)	Average dosage (course)	Outcome (d)
	Hemodynamic change in CE-US	No. of cases (n = 34)	CEM (n = 18)	CEM + CDDP (n = 13)	Chemo + radiation (n = 3)	CR	PR	SD	PD	CA19-9 reduction of less than half (n = 31)	Average dosage (course)	Outcome (d)
R group	Total	18	9	8	1	1	5	10	2	11 (61%)^a	10.2^a	402.0
	Increase (HI)	12	6	5	1	1	3	8	0	8 (67%)^a	10.7 (6-18)^a	411.6 (239-6.4)^a
	No change (II) iso-iso		3	3	0	0	2	2	2	3 (50%)^a	9.0 (1-27)^a	383.5 (109-831)^a
P group	Total	16	9	5	2	0	1	6	9	2 (0.1%)^a	4.9^a	246.0^a
	No change (HH) hypo-hypo	16	9	5	2	0	1	6	9	2 (0.1%)	4.9 (1-12)	246.0 (119-351)
	Decrease (IH)	0	0	0	0	0	0	0	0	0	0	0

^aP < 0.05.

Citation: Sofuni A, Itoi T, Itokawa F, Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Moriyasu F. Usefulness of contrast-enhanced ultrasonography in determining treatment efficacy and outcome after pancreatic cancer chemotherapy. World J Gastroenterol 2008; 14(47): 7183-7191
URL: https://www.wjgnet.com/1007-9327/full/v14/i47/7183.htm
DOI: https://dx.doi.org/10.3748/wjg.14.7183